AASDHPPT (Lys2) as A Potential Drug Target for Various Diseases

Target Name: AASDHPPT

NCBI ID: G60496

AASDHPPT

AASDHPPT (Lys2) as A Potential Drug Target for Various Diseases

AASDHPPT (Lys2) is a protein that is expressed in various tissues of the body, including the brain. It is a key player in the regulation of cell growth and differentiation, and is involved in the development and maintenance of tissues such as muscles, bones, and the nervous system.

Recent studies have identified AASDHPPT (Lys2) as a potential drug target (or biomarker) for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and biology make it an attractive target for drug development due to its potential to modulate cellular processes that are associated with the disease.

One of the key features of AASDHPPT (Lys2) is its role in the regulation of cell growth and differentiation. It is a key regulator of the myoblast cell cycle, which is responsible for the formation and maintenance of muscle tissue. By controlling the number of myoblast cells that are recruited to the site of muscle growth, AASDHPPT (Lys2) plays a crucial role in ensuring that the muscle tissue is properly developed and maintained.

In addition to its role in cell growth and differentiation, AASDHPPT (Lys2) is also involved in the regulation of cell survival. Studies have shown that AASDHPPT (Lys2) plays a role in the regulation of apoptosis, which is a natural mechanism that helps cells to remove damaged or dysfunctional parts of themselves. This helps to prevent the formation of dangerous aggregates of cells, which can lead to the development of diseases such as cancer.

Another key aspect of AASDHPPT (Lys2) is its role in the regulation of inflammation. Studies have shown that AASDHPPT (Lys2) is involved in the regulation of the immune response, and is a potential target for the treatment of autoimmune disorders. Additionally, AASDHPPT (Lys2) has also been shown to play a role in the regulation of inflammation in the brain, which is important for the development and maintenance of healthy brain function.

AASDHPPT (Lys2) is also a potential drug target (or biomarker) due to its role in the regulation of pain perception. Studies have shown that AASDHPPT (Lys2) is involved in the regulation of pain perception and that it may be a potential target for the treatment of chronic pain disorders.

In conclusion, AASDHPPT (Lys2) is a protein that is expressed in various tissues of the body, and is involved in the regulation of cell growth and differentiation, cell survival, and inflammation. Its unique structure and biology make it an attractive target for drug development, and recent studies have identified its potential as a drug target (or biomarker) for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of AASDHPPT (Lys2) in the development and treatment of these diseases.

Protein Name: Aminoadipate-semialdehyde Dehydrogenase-phosphopantetheinyl Transferase

Functions: Catalyzes the post-translational modification of target proteins by phosphopantetheine. Can transfer the 4'-phosphopantetheine moiety from coenzyme A, regardless of whether the CoA is presented in the free thiol form or as an acetyl thioester, to a serine residue of a broad range of acceptors including the acyl carrier domain of FASN

The "AASDHPPT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AASDHPPT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets